Share Price and Basic Stock Data
Last Updated: December 15, 2025, 1:32 pm
| PEG Ratio | 1.04 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Alembic Ltd, primarily operating in the realty sector, has demonstrated a notable trajectory in its revenue generation over the past few quarters. For instance, the company’s revenue for the trailing twelve months (TTM) was reported at ₹221 Cr, with a significant increase from ₹127 Cr in FY 2023. The quarterly sales figures reveal a consistent pattern, with the latest quarter ending March 2025 recording sales of ₹60 Cr. This upward trend is indicative of robust demand in the real estate market, especially as the company reported a steady sales figure of ₹51 Cr for June 2024. However, it’s worth noting that expenses have also escalated, rising to ₹128 Cr in FY 2025, which could compress profit margins if not managed effectively. With a market capitalization of ₹2,512 Cr and a price-to-earnings (P/E) ratio of 7.75, Alembic appears to be positioned relatively attractively compared to its peers in the sector, suggesting potential for growth given the right market conditions.
Profitability and Efficiency Metrics
The profitability metrics of Alembic Ltd reflect a company that is steadily improving its operational efficiency. The operating profit margin (OPM) for FY 2025 stood at an impressive 42%, a significant increase from 32% in FY 2023. This upward movement indicates effective cost management and operational efficiency amidst rising expenses. The net profit for the same period was reported at ₹311 Cr, which is a commendable recovery from the previous year’s ₹191 Cr. Additionally, the return on equity (ROE) is at 13.7%, which is a respectable figure in the real estate sector, indicating effective use of shareholder funds. However, the return on capital employed (ROCE) at 6.90% suggests that while profitability is on the rise, there is still room for improvement in how capital is utilized to generate returns. The interest coverage ratio of 68.23x highlights that the company is well-positioned to meet its financial obligations, reflecting a strong operational cash flow.
Balance Sheet Strength and Financial Ratios
Alembic Ltd’s balance sheet reveals a solid financial foundation, characterized by minimal borrowings of just ₹13 Cr against reserves of ₹2,484 Cr. This translates to a debt-to-equity ratio of 0.01, indicating that the company is conservatively financed and less vulnerable to interest rate fluctuations. The current ratio stands at 1.85, suggesting that Alembic maintains a comfortable liquidity position to cover its short-term liabilities. However, the cash conversion cycle (CCC) of 49 days, while improved, remains a critical area for monitoring, as it reflects the efficiency with which the company manages its receivables and inventories. The book value per share has also seen growth, recorded at ₹91.07 for FY 2025, which is encouraging for shareholders looking for value retention. Overall, Alembic’s financial ratios appear to show a company that is managing its resources prudently, although the efficiency in asset turnover could be enhanced.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Alembic Ltd indicates a strong commitment from its promoters, who hold 70.88% of the equity. This level of ownership often translates to enhanced stability and long-term vision for the company, which can be reassuring for minority shareholders. However, foreign institutional investors (FIIs) account for a mere 1.38% of the total shareholding, which could signal limited interest from global investors. Domestic institutional investors (DIIs) hold a negligible 0.05%, raising questions about the broader institutional confidence in the company’s growth trajectory. The public shareholding stands at 27.68%, with the total number of shareholders reported at 1,06,470, which reflects a healthy retail investor base. This mix of shareholders suggests that while there is strong promoter support, attracting institutional investment could be crucial for enhancing credibility and market perception.
Outlook, Risks, and Final Insight
Looking ahead, Alembic Ltd appears poised for growth, primarily driven by its improving operational metrics and a solid balance sheet. However, risks remain, particularly regarding the rising cost pressures reflected in the increasing expense ratios, which could impact future profitability. Additionally, the limited interest from institutional investors could weigh on stock liquidity and market sentiment. As the real estate sector is also subject to regulatory changes and economic fluctuations, investors should remain vigilant about external market conditions. Overall, while Alembic’s fundamentals appear strong, potential investors should weigh these risks against the backdrop of the company’s operational improvements and solid financial health. A balanced approach, focusing on both strengths and vulnerabilities, will be essential for making informed investment decisions in this evolving landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Hampton Sky Realty Ltd | 363 Cr. | 13.2 | 35.8/12.3 | 5.03 | 0.00 % | 6.07 % | 3.84 % | 1.00 | |
| Grovy India Ltd | 62.7 Cr. | 47.0 | 58.8/37.0 | 17.9 | 16.5 | 0.21 % | 7.63 % | 9.12 % | 10.0 |
| Gothi Plascon (India) Ltd | 42.1 Cr. | 41.2 | 53.6/37.8 | 24.2 | 12.1 | 4.85 % | 18.8 % | 14.2 % | 10.0 |
| Generic Engineering Construction & Projects Ltd | 267 Cr. | 46.9 | 55.9/22.0 | 21.9 | 50.6 | 0.00 % | 7.55 % | 2.97 % | 5.00 |
| Garnet Construction Ltd | 95.1 Cr. | 68.4 | 77.8/21.6 | 3.69 | 91.8 | 0.00 % | 9.96 % | 7.47 % | 10.0 |
| Industry Average | 18,297.20 Cr | 446.64 | 72.68 | 149.11 | 0.58% | 12.33% | 12.56% | 6.13 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 22 | 37 | 31 | 37 | 37 | 32 | 39 | 49 | 51 | 53 | 58 | 60 | 50 |
| Expenses | 17 | 26 | 20 | 24 | 26 | 22 | 28 | 25 | 30 | 33 | 32 | 33 | 30 |
| Operating Profit | 5 | 11 | 10 | 13 | 11 | 10 | 12 | 24 | 20 | 20 | 26 | 27 | 20 |
| OPM % | 25% | 30% | 34% | 36% | 30% | 31% | 30% | 49% | 40% | 37% | 46% | 45% | 39% |
| Other Income | 1 | 59 | 2 | -9 | 3 | 48 | 2 | 2 | 2 | 66 | 4 | 3 | 4 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 1 | 2 | 3 | 3 | 3 | 3 |
| Profit before tax | 4 | 68 | 11 | 3 | 12 | 56 | 11 | 24 | 19 | 82 | 27 | 27 | 20 |
| Tax % | 11% | 10% | 2% | -55% | 14% | 8% | 9% | 12% | 10% | 6% | 5% | 12% | 10% |
| Net Profit | -19 | 115 | 46 | 48 | 44 | 91 | 61 | 72 | 56 | 121 | 65 | 68 | 62 |
| EPS in Rs | -0.72 | 4.49 | 1.78 | 1.88 | 1.73 | 3.53 | 2.39 | 2.81 | 2.17 | 4.71 | 2.55 | 2.67 | 2.40 |
Last Updated: August 20, 2025, 2:05 pm
Below is a detailed analysis of the quarterly data for Alembic Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 50.00 Cr.. The value appears to be declining and may need further review. It has decreased from 60.00 Cr. (Mar 2025) to 50.00 Cr., marking a decrease of 10.00 Cr..
- For Expenses, as of Jun 2025, the value is 30.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 33.00 Cr. (Mar 2025) to 30.00 Cr., marking a decrease of 3.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 20.00 Cr.. The value appears to be declining and may need further review. It has decreased from 27.00 Cr. (Mar 2025) to 20.00 Cr., marking a decrease of 7.00 Cr..
- For OPM %, as of Jun 2025, the value is 39.00%. The value appears to be declining and may need further review. It has decreased from 45.00% (Mar 2025) to 39.00%, marking a decrease of 6.00%.
- For Other Income, as of Jun 2025, the value is 4.00 Cr.. The value appears strong and on an upward trend. It has increased from 3.00 Cr. (Mar 2025) to 4.00 Cr., marking an increase of 1.00 Cr..
- For Interest, as of Jun 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 20.00 Cr.. The value appears to be declining and may need further review. It has decreased from 27.00 Cr. (Mar 2025) to 20.00 Cr., marking a decrease of 7.00 Cr..
- For Tax %, as of Jun 2025, the value is 10.00%. The value appears to be improving (decreasing) as expected. It has decreased from 12.00% (Mar 2025) to 10.00%, marking a decrease of 2.00%.
- For Net Profit, as of Jun 2025, the value is 62.00 Cr.. The value appears to be declining and may need further review. It has decreased from 68.00 Cr. (Mar 2025) to 62.00 Cr., marking a decrease of 6.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 2.40. The value appears to be declining and may need further review. It has decreased from 2.67 (Mar 2025) to 2.40, marking a decrease of 0.27.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:41 am
| Metric | Mar 2010 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,121 | 144 | 134 | 147 | 125 | 124 | 74 | 74 | 78 | 127 | 157 | 222 | 224 |
| Expenses | 1,018 | 134 | 128 | 140 | 114 | 106 | 71 | 62 | 64 | 87 | 101 | 128 | 127 |
| Operating Profit | 103 | 10 | 6 | 7 | 11 | 18 | 3 | 11 | 14 | 40 | 57 | 94 | 97 |
| OPM % | 9% | 7% | 5% | 5% | 9% | 15% | 4% | 15% | 18% | 32% | 36% | 42% | 43% |
| Other Income | 16 | 21 | 25 | 25 | 37 | 29 | 93 | 10 | 89 | 54 | 55 | 75 | 76 |
| Interest | 32 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 |
| Depreciation | 43 | 6 | 6 | 5 | 4 | 3 | 3 | 4 | 5 | 7 | 8 | 11 | 11 |
| Profit before tax | 44 | 23 | 25 | 27 | 44 | 45 | 93 | 17 | 98 | 87 | 103 | 156 | 159 |
| Tax % | 10% | -3% | 2% | -3% | 5% | 8% | 0% | 19% | 12% | 7% | 10% | 7% | |
| Net Profit | 40 | 107 | 235 | 145 | 163 | 213 | 329 | 343 | 222 | 191 | 269 | 311 | 324 |
| EPS in Rs | 1.48 | 3.99 | 8.78 | 5.45 | 6.10 | 8.30 | 12.82 | 13.35 | 8.65 | 7.42 | 10.46 | 12.10 | 12.62 |
| Dividend Payout % | 17% | 4% | 2% | 4% | 3% | 2% | 5% | 2% | 21% | 30% | 23% | 20% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 119.63% | -38.30% | 12.41% | 30.67% | 54.46% | 4.26% | -35.28% | -13.96% | 40.84% | 15.61% |
| Change in YoY Net Profit Growth (%) | 0.00% | -157.92% | 50.71% | 18.26% | 23.79% | -50.20% | -39.53% | 21.31% | 54.80% | -25.22% |
Alembic Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 25% |
| 3 Years: | 42% |
| TTM: | 29% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | -1% |
| 3 Years: | 12% |
| TTM: | 13% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 2% |
| 3 Years: | 13% |
| 1 Year: | -33% |
| Return on Equity | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 12% |
| 3 Years: | 12% |
| Last Year: | 14% |
Last Updated: September 4, 2025, 10:45 pm
Balance Sheet
Last Updated: December 4, 2025, 12:55 am
| Month | Mar 2010 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 27 | 53 | 53 | 53 | 53 | 51 | 51 | 51 | 51 | 51 | 51 | 51 | 51 |
| Reserves | 311 | 474 | 750 | 858 | 1,032 | 1,157 | 1,367 | 2,246 | 2,445 | 2,027 | 2,134 | 2,287 | 2,484 |
| Borrowings | 408 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 14 | 13 |
| Other Liabilities | 251 | 91 | 64 | 81 | 73 | 57 | 53 | 112 | 135 | 127 | 134 | 150 | 179 |
| Total Liabilities | 997 | 619 | 875 | 992 | 1,159 | 1,266 | 1,471 | 2,409 | 2,632 | 2,205 | 2,329 | 2,503 | 2,727 |
| Fixed Assets | 393 | 169 | 146 | 171 | 179 | 209 | 225 | 265 | 297 | 321 | 369 | 409 | 426 |
| CWIP | 4 | 2 | 0 | 0 | 0 | 0 | 3 | 6 | 0 | 0 | 1 | 0 | 0 |
| Investments | 8 | 299 | 605 | 732 | 913 | 1,001 | 1,133 | 2,047 | 2,208 | 1,754 | 1,786 | 1,900 | 2,115 |
| Other Assets | 591 | 149 | 124 | 89 | 67 | 55 | 110 | 91 | 127 | 130 | 173 | 194 | 185 |
| Total Assets | 997 | 619 | 875 | 992 | 1,159 | 1,266 | 1,471 | 2,409 | 2,632 | 2,205 | 2,329 | 2,503 | 2,727 |
Below is a detailed analysis of the balance sheet data for Alembic Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 51.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 51.00 Cr..
- For Reserves, as of Sep 2025, the value is 2,484.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,287.00 Cr. (Mar 2025) to 2,484.00 Cr., marking an increase of 197.00 Cr..
- For Borrowings, as of Sep 2025, the value is 13.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 14.00 Cr. (Mar 2025) to 13.00 Cr., marking a decrease of 1.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 179.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 150.00 Cr. (Mar 2025) to 179.00 Cr., marking an increase of 29.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 2,727.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,503.00 Cr. (Mar 2025) to 2,727.00 Cr., marking an increase of 224.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 426.00 Cr.. The value appears strong and on an upward trend. It has increased from 409.00 Cr. (Mar 2025) to 426.00 Cr., marking an increase of 17.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 2,115.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,900.00 Cr. (Mar 2025) to 2,115.00 Cr., marking an increase of 215.00 Cr..
- For Other Assets, as of Sep 2025, the value is 185.00 Cr.. The value appears to be declining and may need further review. It has decreased from 194.00 Cr. (Mar 2025) to 185.00 Cr., marking a decrease of 9.00 Cr..
- For Total Assets, as of Sep 2025, the value is 2,727.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,503.00 Cr. (Mar 2025) to 2,727.00 Cr., marking an increase of 224.00 Cr..
Notably, the Reserves (2,484.00 Cr.) exceed the Borrowings (13.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2010 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2010 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -305.00 | 10.00 | -3.00 | 7.00 | 11.00 | 18.00 | 3.00 | 11.00 | 14.00 | 40.00 | 48.00 | 80.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2010 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 63 | 122 | 76 | 54 | 74 | 40 | 44 | 69 | 71 | 67 | 46 | 49 |
| Inventory Days | 158 | 880 | 659 | 438 | 247 | 289 | 411 | 2,112 | 2,885 | 3,694 | ||
| Days Payable | 128 | 200 | 144 | 128 | 125 | 202 | 151 | 693 | 640 | 1,237 | ||
| Cash Conversion Cycle | 93 | 801 | 591 | 364 | 195 | 126 | 305 | 1,488 | 2,316 | 67 | 2,502 | 49 |
| Working Capital Days | 108 | 235 | 172 | 39 | 20 | 13 | 22 | 97 | 223 | 118 | 77 | 57 |
| ROCE % | 10% | 4% | 4% | 4% | 4% | 7% | 1% | 4% | 4% | 5% | 7% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| SBI Small Cap Fund | 10,000,000 | 0.39 | 81.35 | 10,000,000 | 2025-04-22 14:12:25 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 12.10 | 10.46 | 7.42 | 8.65 | 13.35 |
| Diluted EPS (Rs.) | 12.10 | 10.46 | 7.42 | 8.65 | 13.35 |
| Cash EPS (Rs.) | 6.04 | 3.92 | 3.40 | 3.55 | 0.69 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 91.07 | 85.11 | 80.93 | 97.23 | 89.45 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 91.07 | 85.11 | 80.93 | 97.23 | 89.45 |
| Revenue From Operations / Share (Rs.) | 8.64 | 6.13 | 4.96 | 3.05 | 2.86 |
| PBDIT / Share (Rs.) | 6.57 | 4.35 | 4.07 | 4.02 | 0.83 |
| PBIT / Share (Rs.) | 6.15 | 4.04 | 3.81 | 3.83 | 0.67 |
| PBT / Share (Rs.) | 6.06 | 4.00 | 3.38 | 3.81 | 0.66 |
| Net Profit / Share (Rs.) | 5.63 | 3.62 | 3.14 | 3.36 | 0.53 |
| NP After MI And SOA / Share (Rs.) | 12.10 | 10.46 | 7.42 | 8.65 | 13.35 |
| PBDIT Margin (%) | 75.98 | 70.88 | 82.20 | 131.82 | 29.03 |
| PBIT Margin (%) | 71.19 | 65.90 | 76.91 | 125.60 | 23.67 |
| PBT Margin (%) | 70.08 | 65.20 | 68.21 | 125.10 | 23.18 |
| Net Profit Margin (%) | 65.15 | 58.96 | 63.35 | 110.19 | 18.82 |
| NP After MI And SOA Margin (%) | 140.01 | 170.56 | 149.83 | 283.89 | 466.35 |
| Return on Networth / Equity (%) | 13.28 | 12.29 | 9.17 | 8.89 | 14.92 |
| Return on Capital Employeed (%) | 6.60 | 4.63 | 4.61 | 3.83 | 0.74 |
| Return On Assets (%) | 12.41 | 11.53 | 8.64 | 8.43 | 14.23 |
| Total Debt / Equity (X) | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover Ratio (%) | 0.09 | 0.06 | 0.05 | 0.04 | 0.06 |
| Current Ratio (X) | 1.85 | 1.52 | 2.05 | 2.12 | 1.72 |
| Quick Ratio (X) | 0.95 | 0.49 | 0.99 | 0.83 | 0.80 |
| Inventory Turnover Ratio (X) | 0.08 | 0.09 | 0.07 | 0.12 | 0.26 |
| Dividend Payout Ratio (NP) (%) | 19.83 | 21.03 | 24.24 | 2.31 | 4.49 |
| Dividend Payout Ratio (CP) (%) | 19.18 | 20.43 | 23.41 | 2.26 | 4.44 |
| Earning Retention Ratio (%) | 80.17 | 78.97 | 75.76 | 97.69 | 95.51 |
| Cash Earning Retention Ratio (%) | 80.82 | 79.57 | 76.59 | 97.74 | 95.56 |
| Interest Coverage Ratio (X) | 68.23 | 100.70 | 224.79 | 265.00 | 58.96 |
| Interest Coverage Ratio (Post Tax) (X) | 59.51 | 84.77 | 197.06 | 222.52 | 39.24 |
| Enterprise Value (Cr.) | 2539.12 | 2154.92 | 1520.56 | 1855.97 | 2634.71 |
| EV / Net Operating Revenue (X) | 11.44 | 13.68 | 11.95 | 23.73 | 35.84 |
| EV / EBITDA (X) | 15.06 | 19.30 | 14.54 | 18.00 | 123.44 |
| MarketCap / Net Operating Revenue (X) | 11.40 | 13.64 | 11.97 | 23.75 | 35.92 |
| Retention Ratios (%) | 80.16 | 78.96 | 75.75 | 97.68 | 95.50 |
| Price / BV (X) | 1.08 | 0.98 | 0.73 | 0.74 | 1.15 |
| Price / Net Operating Revenue (X) | 11.40 | 13.64 | 11.97 | 23.75 | 35.93 |
| EarningsYield | 0.12 | 0.12 | 0.12 | 0.11 | 0.12 |
After reviewing the key financial ratios for Alembic Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 12.10. This value is within the healthy range. It has increased from 10.46 (Mar 24) to 12.10, marking an increase of 1.64.
- For Diluted EPS (Rs.), as of Mar 25, the value is 12.10. This value is within the healthy range. It has increased from 10.46 (Mar 24) to 12.10, marking an increase of 1.64.
- For Cash EPS (Rs.), as of Mar 25, the value is 6.04. This value is within the healthy range. It has increased from 3.92 (Mar 24) to 6.04, marking an increase of 2.12.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.07. It has increased from 85.11 (Mar 24) to 91.07, marking an increase of 5.96.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.07. It has increased from 85.11 (Mar 24) to 91.07, marking an increase of 5.96.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 8.64. It has increased from 6.13 (Mar 24) to 8.64, marking an increase of 2.51.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 6.57. This value is within the healthy range. It has increased from 4.35 (Mar 24) to 6.57, marking an increase of 2.22.
- For PBIT / Share (Rs.), as of Mar 25, the value is 6.15. This value is within the healthy range. It has increased from 4.04 (Mar 24) to 6.15, marking an increase of 2.11.
- For PBT / Share (Rs.), as of Mar 25, the value is 6.06. This value is within the healthy range. It has increased from 4.00 (Mar 24) to 6.06, marking an increase of 2.06.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 5.63. This value is within the healthy range. It has increased from 3.62 (Mar 24) to 5.63, marking an increase of 2.01.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 12.10. This value is within the healthy range. It has increased from 10.46 (Mar 24) to 12.10, marking an increase of 1.64.
- For PBDIT Margin (%), as of Mar 25, the value is 75.98. This value is within the healthy range. It has increased from 70.88 (Mar 24) to 75.98, marking an increase of 5.10.
- For PBIT Margin (%), as of Mar 25, the value is 71.19. This value exceeds the healthy maximum of 20. It has increased from 65.90 (Mar 24) to 71.19, marking an increase of 5.29.
- For PBT Margin (%), as of Mar 25, the value is 70.08. This value is within the healthy range. It has increased from 65.20 (Mar 24) to 70.08, marking an increase of 4.88.
- For Net Profit Margin (%), as of Mar 25, the value is 65.15. This value exceeds the healthy maximum of 10. It has increased from 58.96 (Mar 24) to 65.15, marking an increase of 6.19.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 140.01. This value exceeds the healthy maximum of 20. It has decreased from 170.56 (Mar 24) to 140.01, marking a decrease of 30.55.
- For Return on Networth / Equity (%), as of Mar 25, the value is 13.28. This value is below the healthy minimum of 15. It has increased from 12.29 (Mar 24) to 13.28, marking an increase of 0.99.
- For Return on Capital Employeed (%), as of Mar 25, the value is 6.60. This value is below the healthy minimum of 10. It has increased from 4.63 (Mar 24) to 6.60, marking an increase of 1.97.
- For Return On Assets (%), as of Mar 25, the value is 12.41. This value is within the healthy range. It has increased from 11.53 (Mar 24) to 12.41, marking an increase of 0.88.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.09. It has increased from 0.06 (Mar 24) to 0.09, marking an increase of 0.03.
- For Current Ratio (X), as of Mar 25, the value is 1.85. This value is within the healthy range. It has increased from 1.52 (Mar 24) to 1.85, marking an increase of 0.33.
- For Quick Ratio (X), as of Mar 25, the value is 0.95. This value is below the healthy minimum of 1. It has increased from 0.49 (Mar 24) to 0.95, marking an increase of 0.46.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.08. This value is below the healthy minimum of 4. It has decreased from 0.09 (Mar 24) to 0.08, marking a decrease of 0.01.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 19.83. This value is below the healthy minimum of 20. It has decreased from 21.03 (Mar 24) to 19.83, marking a decrease of 1.20.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 19.18. This value is below the healthy minimum of 20. It has decreased from 20.43 (Mar 24) to 19.18, marking a decrease of 1.25.
- For Earning Retention Ratio (%), as of Mar 25, the value is 80.17. This value exceeds the healthy maximum of 70. It has increased from 78.97 (Mar 24) to 80.17, marking an increase of 1.20.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 80.82. This value exceeds the healthy maximum of 70. It has increased from 79.57 (Mar 24) to 80.82, marking an increase of 1.25.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 68.23. This value is within the healthy range. It has decreased from 100.70 (Mar 24) to 68.23, marking a decrease of 32.47.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 59.51. This value is within the healthy range. It has decreased from 84.77 (Mar 24) to 59.51, marking a decrease of 25.26.
- For Enterprise Value (Cr.), as of Mar 25, the value is 2,539.12. It has increased from 2,154.92 (Mar 24) to 2,539.12, marking an increase of 384.20.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 11.44. This value exceeds the healthy maximum of 3. It has decreased from 13.68 (Mar 24) to 11.44, marking a decrease of 2.24.
- For EV / EBITDA (X), as of Mar 25, the value is 15.06. This value exceeds the healthy maximum of 15. It has decreased from 19.30 (Mar 24) to 15.06, marking a decrease of 4.24.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 11.40. This value exceeds the healthy maximum of 3. It has decreased from 13.64 (Mar 24) to 11.40, marking a decrease of 2.24.
- For Retention Ratios (%), as of Mar 25, the value is 80.16. This value exceeds the healthy maximum of 70. It has increased from 78.96 (Mar 24) to 80.16, marking an increase of 1.20.
- For Price / BV (X), as of Mar 25, the value is 1.08. This value is within the healthy range. It has increased from 0.98 (Mar 24) to 1.08, marking an increase of 0.10.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 11.40. This value exceeds the healthy maximum of 3. It has decreased from 13.64 (Mar 24) to 11.40, marking a decrease of 2.24.
- For EarningsYield, as of Mar 25, the value is 0.12. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.12.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Alembic Ltd:
- Net Profit Margin: 65.15%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 6.6% (Industry Average ROCE: 12.33%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 13.28% (Industry Average ROE: 12.56%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 59.51
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.95
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 8.19 (Industry average Stock P/E: 72.68)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.01
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 65.15%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Realty | Alembic Road, Vadodra Gujarat 390003 | alembic.investors@alembic.co.in http://www.alembiclimited.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Chirayu Amin | Chairman |
| Mrs. Malika Amin | Managing Director & CEO |
| Mrs. Rati Desai | Independent Director |
| Mr. Mayurdhvaj Jadeja | Independent Director |
| Mr. Sanjeev Shah | Independent Director |
| Dr. Girish Hirode | Independent Director |
| Mr. Udit Amin | Director |
| Mr. Jain Parkash | Director |
FAQ
What is the intrinsic value of Alembic Ltd?
Alembic Ltd's intrinsic value (as of 15 December 2025) is 90.75 which is 11.89% lower the current market price of 103.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 2,645 Cr. market cap, FY2025-2026 high/low of 152/85.5, reserves of ₹2,484 Cr, and liabilities of 2,727 Cr.
What is the Market Cap of Alembic Ltd?
The Market Cap of Alembic Ltd is 2,645 Cr..
What is the current Stock Price of Alembic Ltd as on 15 December 2025?
The current stock price of Alembic Ltd as on 15 December 2025 is 103.
What is the High / Low of Alembic Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Alembic Ltd stocks is 152/85.5.
What is the Stock P/E of Alembic Ltd?
The Stock P/E of Alembic Ltd is 8.19.
What is the Book Value of Alembic Ltd?
The Book Value of Alembic Ltd is 98.8.
What is the Dividend Yield of Alembic Ltd?
The Dividend Yield of Alembic Ltd is 2.33 %.
What is the ROCE of Alembic Ltd?
The ROCE of Alembic Ltd is 6.90 %.
What is the ROE of Alembic Ltd?
The ROE of Alembic Ltd is 13.7 %.
What is the Face Value of Alembic Ltd?
The Face Value of Alembic Ltd is 2.00.